|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.746
|
Human |
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.684
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.584
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.532
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.526
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.514
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.508
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.469
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.467
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.427
|
Mouse |
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.409
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.381
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.353
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.339
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.336
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.333
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.312
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.297
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.293
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.267
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.263
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.260
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.257
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.248
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.242
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.240
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.237
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.235
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.233
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.226
|
Mouse |
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.220
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.219
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.216
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.214
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.202
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.192
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.190
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.190
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.187
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.185
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.184
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.183
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.178
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.176
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.174
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.174
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.171
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.167
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.166
|
Human |
|
|
protein processing
|
GO:0016485 |
163 |
0.164
|
Human Mouse |
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.164
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.156
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.156
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.155
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.151
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.148
|
Mouse |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.146
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.145
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.143
|
Human |
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.143
|
Human |
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.142
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.140
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.139
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.138
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.133
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.133
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.131
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.131
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.130
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.127
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.127
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.125
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.124
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.123
|
Human |
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.122
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.121
|
Human Mouse |
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.121
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.121
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.116
|
Mouse |
|
|
cytokine production
|
GO:0001816 |
319 |
0.115
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.115
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.114
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.112
|
Mouse |
|
|
lipid transport
|
GO:0006869 |
98 |
0.112
|
Rat |
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.111
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.111
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.109
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.109
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.109
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.108
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.105
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.105
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.104
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.103
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.101
|
Human |
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.100
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.099
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.097
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.092
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.090
|
Human |
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.089
|
Human |
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.089
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.087
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.087
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.087
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.086
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.086
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.086
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.085
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.085
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.084
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.084
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.083
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.082
|
Rat |
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.081
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.080
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.080
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.079
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.079
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.078
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.078
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.077
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.076
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.076
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.075
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.075
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.074
|
Human |
|
|
response to peptide
|
GO:1901652 |
136 |
0.073
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.072
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.072
|
Human |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.071
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.070
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.070
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.069
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.068
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.067
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.066
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.065
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.065
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.065
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.064
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.064
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.064
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.062
|
Human |
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.062
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.062
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.062
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.061
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.061
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.061
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.061
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.060
|
|
|
|
negative regulation of iron ion transport
|
GO:0034757 |
1 |
0.060
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.060
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.059
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.059
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.059
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.059
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.058
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.058
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.058
|
Human |
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.058
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.057
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.057
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.057
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.056
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.055
|
Mouse |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.055
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.055
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.055
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.054
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.054
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.054
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.053
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.053
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.053
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.053
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.052
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.052
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.052
|
Mouse |
|
|
circulatory system process
|
GO:0003013 |
197 |
0.052
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.052
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.051
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.051
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.051
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.051
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.050
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.050
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.050
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.049
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.049
|
Mouse |
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.049
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.047
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.047
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.047
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.046
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.046
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.046
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.046
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.046
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.045
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.045
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.044
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.044
|
|
|
|
positive regulation of systemic arterial blood pressure
|
GO:0003084 |
9 |
0.044
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.044
|
Mouse |
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.043
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.043
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.043
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.042
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.042
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.042
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.041
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.041
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.041
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.041
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.041
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.040
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.040
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.040
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.040
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.039
|
Mouse |
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.039
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.039
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.039
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.039
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.039
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.039
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.039
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.038
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.038
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.038
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.038
|
Mouse |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.038
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.038
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.037
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.037
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.037
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.037
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.036
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.036
|
Mouse |
|
|
ossification
|
GO:0001503 |
216 |
0.036
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.036
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.035
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.035
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.035
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.035
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.035
|
Human |
|
|
organelle assembly
|
GO:0070925 |
177 |
0.034
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.034
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.034
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.034
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.034
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.034
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.034
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.034
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.034
|
Mouse |
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.034
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.034
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.034
|
Mouse |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.034
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.034
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.034
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.034
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.033
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.033
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.033
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.033
|
Human |
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.033
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.033
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.033
|
Mouse |
|
|
response to insulin
|
GO:0032868 |
100 |
0.033
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.032
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.032
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.032
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.032
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.032
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.032
|
Mouse |
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.031
|
Human |
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.031
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.031
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.031
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.031
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.031
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.031
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.031
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.031
|
Human |
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.031
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.030
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.030
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.030
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.030
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.029
|
Human |
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.029
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.029
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.029
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.029
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.029
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.029
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.029
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.029
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.029
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.028
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.028
|
Mouse |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.028
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.028
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.028
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.028
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.028
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.028
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.027
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.027
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.027
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.027
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.027
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.027
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.027
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.027
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.026
|
Mouse |
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.026
|
|
|
|
progesterone biosynthetic process
|
GO:0006701 |
1 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.026
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.026
|
Human |
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.026
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.025
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.025
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.025
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.025
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.025
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
30 |
0.025
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.025
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.025
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.025
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.025
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.025
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
7 |
0.024
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.024
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.024
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.024
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.024
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.024
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.023
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.023
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.023
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.023
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.023
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.023
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.023
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.023
|
Mouse |
|
|
response to inactivity
|
GO:0014854 |
4 |
0.023
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.023
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.023
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.023
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.023
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.022
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.022
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.022
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.022
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.022
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.022
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.022
|
Mouse |
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.022
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.022
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.022
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.022
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.021
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.021
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
regulation of lipoprotein metabolic process
|
GO:0050746 |
4 |
0.021
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.021
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.021
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.021
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.021
|
Human |
|
|
response to estrogen
|
GO:0043627 |
24 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.020
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.020
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.020
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.020
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.020
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.020
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.020
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.020
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.020
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.020
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.020
|
Human |
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.020
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.019
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.019
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.019
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.019
|
Mouse |
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.019
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.019
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.019
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.019
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.019
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.019
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.019
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.019
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.019
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.019
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.018
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.018
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.018
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.018
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.018
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.018
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.018
|
Mouse |
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.018
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.018
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.018
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.018
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.018
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.018
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.017
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.017
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.017
|
Mouse |
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.017
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.017
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.017
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.017
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.017
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.017
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.017
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.017
|
Human |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.017
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.017
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.017
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.017
|
|
|
|
ethanol metabolic process
|
GO:0006067 |
3 |
0.017
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.017
|
Mouse |